Loading clinical trials...
Loading clinical trials...
The influence of postmenopausal hormone treatment on dementia is not clear. Dysfunctions in the metabolism of amyloid in the disease of Alzheimer result in an elevated presence of degradation products...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Ghent
NCT05877196 · Mild Cognitive Impairment, Alzheimer Disease, and more
NCT07545473 · Dementia, Neurodegenerative Diseases, and more
NCT04570085 · Alzheimer Disease
NCT07531732 · Frontotemporal Dementia, Behavioral Variant, Alzheimer Disease
NCT07279714 · Alzheimer s Disease, Alzheimer Dementia, and more
Ghent university hospital
Ghent
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions